Myeloid Clusters Are Associated with a Pro-Metastatic Environment and Poor Prognosis in Smoking-Related Early Stage Non-Small Cell Lung Cancer

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Zhang, Wang ^a   Pal, Sumanta K ^a   Liu, Xueli ^a   Yang, Chunmei ^a   Allahabadi, Sachin ^b   Bhanji, Shaira ^c   Figlin, Robert A ^d   Yu, Hua ^a   Reckamp, Karen L ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Rice University   (United States)

^c HARVARD UNIVERSITY   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; STAT3 PROTEIN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; NICOTINE;

ADULT; AGED; ANTHRACOSIS; ARTICLE; BONE MARROW CELL; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOGENESIS; SMOKING; TUMOR MICROENVIRONMENT; DRUG EFFECTS; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MACROPHAGE; METABOLISM; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOLOGY; PHENOTYPE; PROGNOSIS; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTHRACOSIS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MACROPHAGES; MALE; MIDDLE AGED; MYELOID CELLS; NEOPLASM STAGING; NICOTINE; PHENOTYPE; PROGNOSIS; SMOKING; STAT3 TRANSCRIPTION FACTOR;

EID: 84878117158     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065121     Document Type: Article

References (34)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. (2004). The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta (GA).
3. Hoffmann D, Hoffmann I, El-Bayoumy K, (2001) The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol 14: 767-790.
4. Hou M, Morishita Y, Iijima T, Mase K, Dai Y, et al. (1998) The implication of anthracosis in the development of pulmonary adenocarcinoma. Jpn J Cancer Res 89: 1251-1256.
5. Parsons A, Daley A, Begh R, Aveyard P, (2010) Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 340: b5569.
6. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V, (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12: 253-268.
7. Yu H, Pardoll D, Jove R, (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809.
8. Zou W, (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5: 263-274.
9. Yu H, Kortylewski M, Pardoll D, (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7: 41-51.
10. Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, et al. (2008) Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest 118: 3367-3377.
11. Perrot I, Blanchard D, Freymond N, Isaac S, Guibert B, et al. (2007) Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. J Immunol 178: 2763-2769.
12. Fridlender ZG, Kapoor V, Buchlis G, Cheng G, Sun J, et al. (2011) Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells. Am J Respir Cell Mol Biol 44: 230-237.
13. Dumitriu IE, Dunbar DR, Howie SE, Sethi T, Gregory CD, (2009) Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 182: 2795-2807.
14. Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, et al. (2005) Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 11: 1314-1321.
15. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, et al. (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2: 289-300.
16. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
17. Hiratsuka S, Watanabe A, Aburatani H, Maru Y, (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8: 1369-1375.
18. Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, et al. (2008) The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10: 1349-1355.
19. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, et al. (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15: 35-44.
20. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, et al. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457: 102-106.
21. Psaila B, Lyden D, (2009) The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9: 285-293.
22. Kowanetz M, Wu X, Lee J, Tan M, Hagenbeek T, et al. (2010) Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci U S A 107: 21248-21255.
23. Hiratsuka S, Duda DG, Huang Y, Goel S, Sugiyama T, et al. (2011) C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells. Proc Natl Acad Sci U S A 108: 302-307.
24. Deng J, Liu Y, Lee H, Herrmann A, Zhang W, et al. (2012) S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 21: 642-654.
25. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, et al. (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2: 706-714.
26. Osaki T, Oyama T, Gu CD, Yamashita T, So T, et al. (2002) Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer. J Clin Oncol 20: 2930-2936.
27. Gu CD, Osaki T, Oyama T, Inoue M, Kodate M, et al. (2002) Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival. Ann Surg 235: 133-139.
28. Rusch VW, Hawes D, Decker PA, Martin SE, Abati A, et al. (2011) Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol 29: 4313-4319.
29. Wang D, Wang J, Li Y, He Z, Zhang Y, (2011) The influence of anthracosis and p16 ink4a gene aberrant methylation on small-sized pulmonary adenocarcinoma. Exp Mol Pathol 90: 131-136.
30. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, et al. (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2: 1096-1103.
31. Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, et al. (2009) CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. BMC Cancer 9: 213.
32. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, et al. (2003) The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167: 1676-1686.
33. Kortylewski M, Kujawski M, Herrmann A, Yang C, Wang L, et al. (2009) Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy. Cancer Res 69: 2497-2505.
34. Ihara S, Kida H, Arase H, Tripathi LP, Chen YA, et al. (2012) Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis. Cancer Res 72: 2990-2999.